DNA Prime/Subunit Boost Using SIV (E660) Based rhFLSC Yields 75% Efficacy Against Cross Clade SIVmac251 Intrarectal Challenge

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES(2013)

引用 0|浏览32
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要